Sanofi (Credit: CBRE)
April 26, 2022 02:18 PM EDTUpdated April 29, 01:49 PM
Deals
Pharma

Sanofi of­floads French rights for an­tipsy­chot­ic to neigh­bor­ing phar­ma

Paul Schloesser

Associate Editor

Sanofi has hand­ed off the French rights to an­ti-psych drug Ter­alithe to a small French phar­ma — both a di­vis­i­ble tablet and a pro­longed-re­lease tablet of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Mi­crosoft-backed Enve­da rais­es $130M for drugs in I&I, obe­si­ty and oth­er ar­eas

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times